| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP and CFO
4 companies
Christine A Tsingos is Director at NVST, with reported holdings spanning 4 companies. Christine A Tsingos's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13.5M at current prices.
Christine A Tsingos's largest disclosed position is in ONTO as Director, worth about $8.7M.
Christine A Tsingos has 47 Form 4 filings on record from March 2015 to May 2026, across 4 companies: Director at Envista (NVST), 2020–2026; Director at Varex Imaging (VREX), 2017–2026; Director at Onto Innovation (ONTO), 2015–2024, and 1 more.
The 97 reported transactions were 37 option exercises, 19 option or other derivative awards, 16 stock awards and 13 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $3.3M.
The largest open-market sale was 4,980 shares of BIO at an average $249.40 on December 14, 2017, about $1.2M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2018 | BIO Bio-Rad Laboratories, Inc. | EVP and CFO | Sell | 1,411 | $248.00 | $349,928.00 | -17.4% | |
| Dec 14, 2017 | BIO Bio-Rad Laboratories, Inc. | EVP and CFO | Sale+OE | 4,980 | $249.40 | $1,242,019.97 | -42.7% | |
| Mar 14, 2016 | BIO Bio-Rad Laboratories, Inc. | EVP and CFO | Sale+OE | 6,630 | $137.67 | $912,755.20 | -58.6% | |
| Sep 14, 2015 | BIO Bio-Rad Laboratories, Inc. | EVP and CFO | Sale+OE | 289 | $138.26 | $39,958.07 | -6.0% | |
| Sep 9, 2015 | BIO Bio-Rad Laboratories, Inc. | EVP and CFO | Sale+OE | 76 | $139.01 | $10,564.76 | -1.8% | |
| Mar 12, 2015 | BIO Bio-Rad Laboratories, Inc. | EVP and CFO | Sale+OE | 5,400 | $135.94 | $734,076.00 | -57.7% |